Cancer Mortality in the United States Is Decreasing Steadily

πŸ“‰ Cancer death rates in the U.S. are improving
Cancer deaths have been going down steadily in the United States over several decades. This means more people diagnosed with cancer are living longer, even with some of the most serious forms of the disease.

πŸ“ˆ More people survive cancer now than in the past
About 7 out of 10 people diagnosed with cancer in the U.S. now live at least five years or more after their diagnosis. That’s a big improvement compared with the mid-1970s, when only around half of people survived that long.

πŸ’‰ Why cancer death rates are decreasing
Researchers say the progress is mainly because of:

  • Better early detection, which helps catch cancers sooner when they are easier to treat.

  • Advances in cancer treatments, including newer therapies like immunotherapy.

For example, survival rates for some cancers that used to be very deadly β€” such as myeloma, liver cancer, and lung cancer β€” have doubled or more when comparing patients from the mid-1990s with patients today.

⚠️ There is still work to do
The article also stresses that while this progress is great news, the fight against cancer isn’t over. A few ongoing challenges include:

  • Some cancers still have low survival rates.

  • The number of people being diagnosed with certain cancers (like breast and prostate) is still rising.

  • There are concerns that reductions in cancer research funding and changes in health insurance access could slow future progress.

πŸ’¬ Bottom line
Thanks to scientific advances and better detection, cancer mortality in the U.S. has fallen, and more people are surviving longer, including cancers that used to be harder to treat. But continued effort in research, early detection, and treatment access is needed to keep improving outcomes for all cancers.

https://www.the-scientist.com/cancer-mortality-in-the-united-states-is-decreasing-steadily-73953?utm_campaign=5750943-TS_News%20Alerts_2025&utm_medium=email&_hsenc=p2ANqtz-8X0DMIjW1bZOPoETwBF-GXIDk5aozTPDW85ONHg8vZB73fcOEVDr91Xh1L32cVHzlB8AWd6YmI-2vFvjIjOVIwXOElnE087MXSPGk24DagYyt9l9g&_hsmi=400384695&utm_content=400384695&utm_source=hs_email

Previous
Previous

Clinical trial including OU patients finds proton therapy improves head, neck cancer survival

Next
Next

Immunotherapy Success Rate for Head and Neck Cancer: What Patients Need to Know In 2025